Post-earnings recap
Reported
Wed, Jul 28, 2021
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
100%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
Thermo Fisher Scientific's earnings report shows a positive surprise in EPS, indicating better-than-expected profitability. However, the stock reacted negatively, declining by 0.38%, likely due to the lack of revenue data and guidance. Investors may be concerned about ongoing supply chain issues and the absence of forward-looking statements from management.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $5.60 | N/A | +1.63% |
| Revenue | N/A | N/A | N/A |
Overall, management expressed a cautious optimism about the company's performance despite external challenges. They are focused on leveraging their strengths to navigate the current environment.
Management highlighted strong demand in key segments.
They noted ongoing challenges in supply chain but remain focused on growth.
There was an emphasis on innovation as a driver for future performance.